The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system
- PMID: 8935161
- DOI: 10.1111/j.2042-7158.1996.tb07112.x
The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system
Abstract
The presence of the blood-brain barrier (BBB), reduces the brain uptake of many drugs, peptides and other solutes from blood. Strategies for increasing the uptake of drugs and peptide-based drugs include; structural modifications to increase plasma half-life; improving passive penetration of the BBB by increasing the lipophilicity of the molecule; designing drugs which react with transporters present in the BBB; and reducing turnover and efflux from the central nervous system (CNS).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
